Carregant...
Changes in treatment landscape of relapsed or refractory multiple myeloma and their association with mortality: Insights from German claims database
OBJECTIVES: Emerging treatments for relapsed or refractory multiple myeloma (rrMM) have led to increasing options for many patients. This study aimed to assess changes in utilization of these options in Germany with a focus on modern triplet regimens including new agents, such as carfilzomib, ixazom...
Guardat en:
| Publicat a: | Eur J Haematol |
|---|---|
| Autors principals: | , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
John Wiley and Sons Inc.
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7894176/ https://ncbi.nlm.nih.gov/pubmed/32989806 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/ejh.13523 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|